In the News

LDN Articles from general news sources

Scientists get first look at T cell responses in Ebola virus survivors (News)
Read More
McLaughlin leads research on identifying minimally invasive biomarkers for MS (News)
Read More
Halberd Corp. Develops Medication to Boost Immune System Against SARS-CoV-2 (Covid-19) (News)
Read More
Low-Dose Naltrexone Used as Alternative to Opioids for Chronic Pain Patients (News)
Read More
Calls for the radical treatment (News)
Read More
Low-Dose Naltrexone May Be Opioid Replacement for Chronic Pain (News)
Read More
Low-dose naltrexone safe, effective for neuropathic corneal pain (News)
Read More
Low dose naltrexone: Harnessing the body's own chemistry to treat human ovarian cancer (News)
Read More
The Use of Naltrexone in Low Doses Beyond the Approved Indication... (News)
Read More
Scientists Think They've Figured Out What's Triggering Brain Fog in COVID-19 Patients (News)
Read More
Impact of Colchicine and Low-dose Naltrexone on COVID-19 (COLTREXONE) (Study)
Read More
What COVID-19 Teaches Us About Rare Diseases (News)
Read More
Low-Dose Naltrexone for Treating MS Symptoms (News)
Read More
Low Dose Naltrexone Easing Pain from Fibromyalgia and Other Painful Conditions (News)
Read More
Low-dose Naltrexone Changes Levels of Inflammatory Proteins in MS, Study Shows (News)
Read More
Low-dose naltrexone: tricking the body to heal itself (News)
Read More
LDN Side Effect Survey Results 2021
Read More
Can common drugs offer 2-step approach to combat deadly virus? (News)
Read More
Medicine specialist talks treatments for lingering COVID-19 symptoms (News)
Read More
Low-Dose Naltrexone for Fibromyalgia and ME/CFS (News)
Read More